| 1 |
35121556 | Dimethoxyindoles based thiosemicarbazones as multi-target agents; synthesis, crystal interactions, biological activity and molecular modeling. | 2022 Mar |
2 |
| 2 |
35227053 | Essential Oil Content, Antioxidative Characteristics and Enzyme Inhibitory Activity of Sideritis akmanii Aytaç, Ekici & Dönmez | 2022 Feb 28 |
1 |
| 3 |
35292697 | Analysis of treatment pattern of anti-dementia medications in newly diagnosed Alzheimer's dementia using OMOP CDM. | 2022 Mar 15 |
1 |
| 4 |
32897587 | New multitarget directed benzimidazole-2-thiol-based heterocycles as prospective anti-radical and anti-Alzheimer's agents. | 2021 Apr |
2 |
| 5 |
33268824 | New therapeutics beyond amyloid-β and tau for the treatment of Alzheimer's disease. | 2021 Sep |
1 |
| 6 |
33704781 | Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis. | 2021 Feb 22 |
1 |
| 7 |
33716687 | Loss of Basal Forebrain Cholinergic Neurons Following Adolescent Binge Ethanol Exposure: Recovery With the Cholinesterase Inhibitor Galantamine. | 2021 |
1 |
| 8 |
33920698 | Treatment of Parkinson's Disease with Cognitive Impairment: Current Approaches and Future Directions. | 2021 Apr 17 |
1 |
| 9 |
34208297 | Biphenylalkoxyamine Derivatives-Histamine H3 Receptor Ligands with Butyrylcholinesterase Inhibitory Activity. | 2021 Jun 11 |
1 |
| 10 |
34299238 | LC-ESI-QTOF-MS/MS Analysis, Cytotoxic, Antiviral, Antioxidant, and Enzyme Inhibitory Properties of Four Extracts of Geranium pyrenaicum Burm. f.: A Good Gift from the Natural Treasure. | 2021 Jul 16 |
1 |
| 11 |
34943074 | Oxidative Stress Biomarkers and Mitochondrial DNA Copy Number Associated with APOE4 Allele and Cholinesterase Inhibitor Therapy in Patients with Alzheimer's Disease. | 2021 Dec 10 |
1 |
| 12 |
31773661 | Cholinesterase as a Target for Drug Development in Alzheimer's Disease. | 2020 |
1 |
| 13 |
32679025 | Current Strategies and Novel Drug Approaches for Alzheimer Disease. | 2020 |
1 |
| 14 |
29247294 | rCBF and cognitive impairment changes assessed by SPECT and ADAS-cog in late-onset Alzheimer's disease after 18 months of treatment with the cholinesterase inhibitors donepezil or galantamine. | 2019 Feb |
1 |
| 15 |
29756568 | Aporphines and Alzheimer's Disease: Towards a Medical Approach Facing the Future. | 2019 |
1 |
| 16 |
30956012 | Design, synthesis, evaluation and molecular modeling study of 4-N-phenylaminoquinolines for Alzheimer disease treatment. | 2019 Jun 1 |
1 |
| 17 |
31165574 | Double-Blind Placebo-Controlled Trial of Galantamine for Methadone-Maintained Individuals With Cocaine Use Disorder: Secondary Analysis of Effects on Illicit Opioid Use. | 2019 Jul |
1 |
| 18 |
31378596 | Microwave-Assisted Organic Synthesis, structure-activity relationship, kinetics and molecular docking studies of non-cytotoxic benzamide derivatives as selective butyrylcholinesterase inhibitors. | 2019 Sep 15 |
1 |
| 19 |
31476160 | Is Combining an Anticholinergic with a Cholinesterase Inhibitor a Good Strategy for High-Level CNS Cholinesterase Inhibition? | 2019 |
2 |
| 20 |
31600664 | New 4-N-phenylaminoquinoline derivatives as antioxidant, metal chelating and cholinesterase inhibitors for Alzheimer's disease. | 2019 Dec |
1 |
| 21 |
31607910 | Antipsychotic Treatment of Behavioral and Psychological Symptoms of Dementia (BPSD): Management of Extrapyramidal Side Effects. | 2019 |
1 |
| 22 |
31757262 | Randomized placebo-controlled trial of galantamine in individuals with cocaine use disorder. | 2019 Dec |
1 |
| 23 |
29044771 | Alkaloids of Amaryllidaceae as Inhibitors of Cholinesterases (AChEs and BChEs): An Integrated Bioguided Study. | 2018 Mar |
1 |
| 24 |
29960246 | Exploring the effects of galantamine paired with meditation and dream reliving on recalled dreams: Toward an integrated protocol for lucid dream induction and nightmare resolution. | 2018 Aug |
1 |
| 25 |
29990843 | A molecular approach in drug development for Alzheimer's disease. | 2018 Oct |
1 |
| 26 |
30079554 | Synthesis, characterization, and SAR of arylated indenoquinoline-based cholinesterase and carbonic anhydrase inhibitors. | 2018 Sep |
1 |
| 27 |
28103749 | Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology. | 2017 Feb |
2 |
| 28 |
28458525 | Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson's disease dementia. | 2017 |
1 |
| 29 |
26769920 | Toxicological Differences Between NMDA Receptor Antagonists and Cholinesterase Inhibitors. | 2016 Aug |
1 |
| 30 |
26833077 | Efficient Synthesis and Discovery of Schiff Bases as Potent Cholinesterase Inhibitors. | 2016 |
1 |
| 31 |
27505087 | Biological evaluation and docking studies of some benzoxazole derivatives as inhibitors of acetylcholinesterase and butyrylcholinesterase. | 2016 Nov 1 |
1 |
| 32 |
25624417 | Combination Therapy of Cholinesterase Inhibitor (Donepezil or Galantamine) plus Memantine in the Okayama Memantine Study. | 2015 |
1 |
| 33 |
25734590 | Cholinesterase inhibitors for rarer dementias associated with neurological conditions. | 2015 Mar 3 |
1 |
| 34 |
25777522 | Galantamine improves sleep quality in patients with dementia. | 2015 Dec |
1 |
| 35 |
24604285 | Microwave-assisted synthesis of novel purine nucleosides as selective cholinesterase inhibitors. | 2014 Apr 21 |
1 |
| 36 |
25411501 | Cholinergic stimulation enhances Bayesian belief updating in the deployment of spatial attention. | 2014 Nov 19 |
2 |
| 37 |
23286718 | Dose and plasma concentration of galantamine in Alzheimer's disease - clinical application. | 2013 |
1 |
| 38 |
23435942 | A review on cholinesterase inhibitors for Alzheimer's disease. | 2013 Apr |
1 |
| 39 |
23732196 | [Drugs used for cognitive impairment. Analysis of 1.5 million prescriptions in Argentina]. | 2013 |
1 |
| 40 |
21818628 | Longitudinal changes of fractional anisotropy in Alzheimer's disease patients treated with galantamine: a 12-month randomized, placebo-controlled, double-blinded study. | 2012 Jun |
1 |
| 41 |
22568060 | [Strategy and perspectives for development of Alzheimer disease-modifying drugs]. | 2012 |
1 |
| 42 |
22665688 | Alzheimer's disease: early diagnosis and treatment. | 2012 Jun |
1 |
| 43 |
22840647 | High-performance liquid chromatography with fast-scanning fluorescence detection and multivariate curve resolution for the efficient determination of galantamine and its main metabolites in serum. | 2012 Aug 31 |
1 |
| 44 |
22992965 | Effect on cognition of galanthamine administered for neuromuscular block reversal in octogenarians undergoing cataract surgery. | 2012 Aug 8 |
1 |
| 45 |
27750512 | Drugs licensed for treating patients with alzheimer's disease. | 2012 Jun 29 |
1 |
| 46 |
20850275 | Galantamine augmentation of long-acting injectable risperidone for cognitive impairments in chronic schizophrenia. | 2011 Feb |
1 |
| 47 |
21088041 | Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology. | 2011 Aug |
1 |
| 48 |
21364371 | Effectiveness of adding memantine to an Alzheimer dementia treatment regimen which already includes stable donepezil therapy: a critically appraised topic. | 2011 Mar |
1 |
| 49 |
21630031 | BCHE and CYP2D6 genetic variation in Alzheimer's disease patients treated with cholinesterase inhibitors. | 2011 Nov |
1 |
| 50 |
21648211 | Bradycardia due to cholinesterase inhibitors: identify adverse effects and take them into account. | 2011 Apr |
1 |